Latest News and Press Releases

NEW HAVEN, Conn., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrphAI Therapeutics Inc. (“OrphAI”), a clinical-stage biopharmaceutical company developing novel therapeutics for diseases with unmet needs,...

35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity

Liquidia Corporation (NASDAQ: LQDA) today reported financial results for the second quarter ended June 30, 2024.

Judge Andrews denied the motion for preliminary injunction filed by United Therapeutics that sought to block the launch of Liquidia’s YUTREPIA™.

Washington, DC, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Medical Inhaled Nitric Oxide Market By Product Type (Inhaled Nitric Oxide Delivery...

Wilmington, Delaware, United States, April 03, 2023 (GLOBE NEWSWIRE) -- According to the market study by Transparency Market Research, the global cardiotonic agents market was worth USD 732 Million...

New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inhaled nitric oxide is a pulmonary vasodilator that considerably controls vascular muscle tone. It has emerged as a therapy for hypoxemic...

New York, USA, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight DelveInsight’s pulmonary hypertension...

BARCELONA, Spain, Feb. 28, 2022 (GLOBE NEWSWIRE) -- In the run up to Rare Disease Day, which is held on 28 February, International pharmaceutical company Ferrer has strengthened its focus on...

SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Halo Biosciences, a clinical stage biopharmaceutical company today announced that its Chief Executive Officer, Anissa Kalinowski, MSc, MBA, will...